002432SZSE

Legal Opinion on Tianjin Nine-An Medical Electronics Co., Ltd.'s 2021 Stock Option Incentive Plan: Cancellation of Partial Stock Options and Fulfillment of Fourth Vesting Period Conditions

Andon Health Co., Ltd.·

✨ AI Summary

This legal opinion confirms that Tianjin Nine-An Medical Electronics Co., Ltd. has obtained necessary approvals for canceling partial stock options and fulfilling the fourth vesting period conditions under its 2021 Stock Option Incentive Plan. The fourth vesting period has concluded, and all conditions have been met. The cancellation and exercise are in compliance with relevant regulations and the company's articles of association.

Summary generated by AI · Always verify with source document

Full Translation

AI Translation· gemini_documentSign In to Upgrade

Legal Opinion

To: Tianjin Nine-An Medical Electronics Co., Ltd.

This firm, as the dedicated legal advisor for Tianjin Nine-An Medical Electronics Co., Ltd. (hereinafter referred to as "Nine-An Medical") regarding its incentive plan, has reviewed the cancellation of previously granted but unexercised stock options under the 2021 Stock Option Incentive Plan (hereinafter referred to as "this Cancellation") and the fulfillment of the conditions for the fourth vesting period (hereinafter referred to as "this Exercise"), in accordance with relevant laws, regulations, normative documents such as the "Company Law," "Securities Law," and "Administrative Measures for Equity Incentives of Listed Companies," and the "Articles of Association" of Nine-An Medical.

To prepare this legal opinion, the firm's lawyers have conducted investigations and verifications. Nine-An Medical has provided written documents to this firm, guaranteeing that all documents and materials provided are complete, true, accurate, and effective. Signatures and seals on the materials are authentic. For any materials provided as copies or duplicates, the originals are consistent with the copies. Statements, explanations, confirmations, and commitments made are true, accurate, and complete, without any false information, omissions, or misleading statements. Other documents and data not produced by the company itself are consistent with the documents and data obtained from the original providers, and have not been altered, deleted, omitted, or concealed in any form. Auxiliary documents and information related to these documents and data have also been provided or disclosed to prevent the firm's reasonable understanding, judgment, and use of these documents and data from being affected by incorrectness or incompleteness. All natural persons related to the company have full civil capacity, and information provided verbally by relevant staff is true.

Sign in to read the full translation

Free accounts get 10 full releases per month. Pro subscribers get unlimited access.